NutraFuels, Inc. Appoints Kenneth Duchin, Ph.D. as Vice-President Clinical Development
February 23, 2017 at 05:30 pm EST
Share
NutraFuels, Inc. (NutraFuels or NTFU) announced the appointment of Kenneth Duchin, Ph.D. as Vice-President Clinical Development and the agreement with Palm Beach Research to conduct clinical studies. The recent growth of NutraFuels has provided the opportunity to explore the benefits of the oral spray product line. Dr. Duchin's career has spanned over 30 years in the pharmaceutical industry in various management positions at Bristol-Myers Squibb and in small and mid-size companies (Theravance, IVAX Corporation, Noven Pharmaceuticals) as well as in start-up virtual organizations. He has extensive drug development experience in a broad range of therapeutic areas, has led several registration programs, authored regulatory NDA and ANDA documents and has led cross-functional development teams.
NutraLife BioSciences, Inc. is engaged in the development and distribution of nutritional and dietary oral spray products. The Company is a producer and distributor of nutritional supplements that uses micro molecular formulae and the utilization of an oral spray to provide efficient absorption. Its products are sold to private label distributors who sell the products it manufactures under their own brand name. The Company manufactures and distributes oral spray nutritional and dietary products. Its distribution strategy includes selling to private label customers retailers, distributors, and consumers through retail outlets. Its wholly owned subsidiaries include Precision Analytic Testing, LLC, NutraDerma Technologies, Inc., PhytoChem Technologies, Inc., and TransDermalRX, Inc.